Amaç: Çalışmamızın amacı tavşan karotis arter anastomoz modelinde gelişen neointimal hiperplazi üzerine bir matriks metalloproteinaz inhibitörü olarak zoledronik asidin (ZA) etkilerini araştırmaktır. Yöntemler: Bu deneysel çalışmada Yeni Zelanda tipi erkek tavşanlar plasebo ve ilaç-tedavi olmak üzere iki gruba ayrılmıştır. Anestezi sonrası, her bir tavşanın sağ karotis arteri 8/0 polipropilen sütür ile uç uca anastomoz edilmiştir. Sol karotis arter ise uygulama olmaksızın kontrol olarak bırakılmıştır. Plasebo grubundaki tavşanlara (n=6) operasyon sonrası 28 gün boyunca PBS (0.5mL/kg/gün/s.k.) uygulanırken ilaç grubundaki tavşanlara (n=6) aynı süre boyunca zoledronik asid (100 μg/kg/gün/s.k.) uygulanmıştır. Sakrifikasyondan sonra anastomozlu ve kontrol arterler izole edilmiştir. Morfometrik ve immünohistokimyasal incelemeler gerçekleştirilmiştir. Morfometrik ve immünohistokimyasal verilerin istatistiksel analizleri sırasıyla çift yönlü ANOVA ve Ki-kare testi ile yapılmıştır. Bulgular: PBS grubunda anastomozlu arterlerde oluşan damar hasarının, kontrol artere kıyasla intimal alanı (kontrol: 22.62±4.26, μm 2 *1000 anastomozlu: 112.51±61.18 μm 2 *1000, p<0.01) ve intima/media indeksini (kontrol: 0.075±0.01, anastomozlu: 0.347±0.29, p<0.05) istatistiksel olarak anlamlı şekilde artırdığı saptanmıştır. Zoledronik asidin, PBS grubuna kıyasla intimal alanı (39.29±18.21 μm 2 *1000, p<0.01) ve intima/media indeksini (0.112±0.07, p<0.05) anlamlı şekilde azaltmıştır. Buna ek olarak, ZA grubundan anastomozlu arterlerde α-düz kas aktin immunpozitivitesi ABSTRACT Objective: The aim of the present study was to investigate the effect of zoledronic acid (ZA), as a matrix metalloproteinase inhibitor, on neointimal hyperplasia in rabbit carotid anastomosis model. Methods: New Zealand male rabbits were divided into two groups as placebo and treatment groups in this experimental study. After anesthesia, the right carotid artery of each rabbit was end-to-end anastomosed with an 8/0 polypropylene suture. Left carotid artery was kept as control without any operation. Placebo group (n=6) received phosphate buffered saline (PBS) (0.5mL/kg/day/s.c.) for 28 days postoperatively, whereas ZA group (n=6) received ZA (100 μg/kg/day/s.c.) for the same period. After sacrification, the anastomosed and control arteries were isolated. Morphometric and immunohistochemical examinations were performed. Statistical analyses of morphometric and immunohistochemical data were performed using two-way ANOVA and Chi-square test respectively. Results: In PBS group, vascular injury in the anastomosed artery significantly increased the intimal area (anastomosed: 112.51±61.18 μm 2 *1000 vs. control: 22.62±4.26μm 2 *1000, p<0.01) and intima/media index (anastomosed: 0.347±0.29 vs. control: 0.075±0.01, p<0.05) compared to control artery. ZA significantly reduced the intimal area (39.29±18.21 μm 2 *1000 , p<0.01) and intima/media index (0.112±0.07, p<0.05) compared to PBS group. Additionally, α-smooth muscle actin immunopositivity was found significantly decreased in anastomosed arteries from ZA group (ZA: 2.33±0.52 vs. PBS: 3.50±0.5, p<0.05). Moreover, intensive gelatinase (MMP-2 and MMP-9) immunoreactivities were clearly seen in anastomosed arteries compared to control arteries from PBS group. ZA apparently decreased immunopositivities for gelatinases in anastomosed arteries. Conclusion: ZA might be a promising agent for prevention of neointimal hyperplasia, which is the most significant cause of graft failures in late postoperative period. (Anadolu Kardiyol Derg 2011; 2: 93-100) 
Introduction
The main reason for early failure of small diameter grafts used in vascular surgery is thrombotic occlusion, whereas the main reason for late failure is neointimal hyperplasia (1) (2) (3) . Therapeutic interventions such as balloon angioplasty, stenting and surgical vascular anastomosis results in arterial injury. Intimal thickening that develops in response to vascular injury is defined as neointimal hyperplasia. Neointimal hyperplasia is the main stage in the pathogenesis of vascular proliferative disorders such as atherosclerosis and restenosis (4) . This process includes extracellular matrix (ECM) degradation, smooth muscle cell (SMC) proliferation and migration (5) . Matrix metalloproteinases (MMPs) are known as the components of a Zn ++ -and Ca ++ -dependent neutral endopeptidase family that degrades ECM components and plays an essential role in SMC proliferation and migration (5, 6) . Studies performed in rat balloon injury model (7) , hypercholesterolemic rabbits (8) and mouse carotid artery ligation model (9) showed that in particular, gelatinases (MMP-2 and MMP-9) play essential role in intimal hyperplasia. Moreover, positive effects of different synthetic MMP inhibitors on SMC proliferation, migration and vascular remodeling have been demonstrated (10) (11) (12) (13) .
On the other hand, bisphosphonates are commonly used for treatment of osteoporosis by inhibiting the osteoclastic activity and bone resorption. They have recently been reported to have an inhibitory effect on the synthesis and activity of MMPs (14, 15) . In most of the studies related to bisphosphonates have been shown to have inhibitory effects on MMP production and activities during tumor growth and invasion. Besides, it was reported that bisphosphonates inhibit SMC proliferation and migration in atherosclerotic animal models and cell culture (16) (17) (18) (19) (20) .
However, antiproliferative effects related to MMP inhibition of biphosphonates in atherosclerosis, which is also a proliferative process remains unclear.
The aim of this study was to investigate the possible inhibitory effects of zoledronic acid (ZA) as an MMP inhibitor on neointimal hyperplasia in a rabbit-model of carotid anastomosis.
Methods
Material and study design This experimental study was approved by the Local Ethics Committee of the Faculty of Medicine, Dokuz Eylül University. All animals received care in compliance with the principles of laboratory animal care formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals.
New Zealand male rabbits (n=12, weight range 2.3-2.9 kg) were randomly divided into two groups. Rabbits in the ZA group (n=6) received ZA (100 μg/kg/day, s.c.) for 28 days postoperatively (18) , whereas rabbits in the phosphate buffered saline (PBS) group (n=6) received only sterile PBS (0.5mL/kg/day, s.c.) for the same period. Throughout the 28-days treatment period each rabbit was kept in a separate cage and allowed to access to regular diet (standard rabbit chow and tap water ad libitum). All animals were well tolerated drug treatment. The treatment protocol did not affect survival rate and body weight of animals from both groups (data not shown).
Implementation of carotid artery anastomosis model
Rabbits were anesthetized with intramuscular xylazine (3 mg/kg) and ketamine (50 mg/kg). The same surgeon (MG) performed all procedures using a 3.5X surgical telescope (US PAT NO: 3273456, Designs for Vision, Ronkonkoma, NY, USA). An oblique cervical incision was made and the right carotid artery was explored. The distal and proximal parts were clamped and the right carotid artery was transected. Both ends were anastomosed in an end-to-end fashion using an 8/0 polypropylene suture (21) . Then, a similar incision was made on the left contralateral carotid artery and a segment from the left carotid artery, which constituted control groups (ZA control and PBS control), was resected. Afterwards, the anatomic layers were closed properly.
Tissue harvesting procedures
On the 28 th postoperative day, the rabbits (n=12) were sacrificed using over dose of xylazine and ketamine. First, the anastomosed right carotid artery segment and then a segment from the contralateral intact carotid artery were isolated. Each segment was put into a tube containing 810% neutral buffered formalin for histological examination.
Morphometry
After formalin fixation of the arteries, paraffin blocks were prepared following routine histological procedures. Fivemicrometre sections were obtained from the prepared paraffin blocks. Sections were stained with hematoxylin and eosin (H&E). All slides were examined by Leica DFC280 light microscope. Leica Q Win and Image Analysis System (Leica Micros Imaging Solutions Ltd., Cambridge, UK) were used for image processing. The luminal, intimal and medial cross-sectional areas of the arteries were measured and the index defined as intimal/medial area ratio was calculated from these measurements.
Immunohistochemistry
The sections were deparaffinized in xylene, rehydrated in graded ethanol and washed with distilled water. The slides were enhanced by boiling the tissue sections in 10 mM citrate buffer at pH 6.0 for 10 minutes followed by cooling at room temperature (RT) for 30 minutes. All tissue sections were rinsed with PBS at pH 7.4; in order to block endogenous peroxidase activity the sections were incubated in 0.3% H 2 O 2 for 30 min, and then washed with PBS. They were then incubated in 10% normal horse serum (NHS) for 20 minutes at 37°C. The NHS and all subsequent reagents were diluted in PBS containing 0.1% bovine serum albumin, 200 μL of the diluted solution was added to each slide and incubated in a moisture chamber (22) . The NHS was removed, and the slides were incubated at 37°C with monoclonal anti α-actin smooth muscle specific antibody (Cat. # A20002, ScyTek Laboratories, Utah, USA) and with antibodies against anti MMP-2 and MMP-9 (Cat. # MAB3308, Cat. # MAB3309 respectively Milipore, CA, USA). After incubation, in order to remove the primary antibody the slides were washed with PBS. Anti-mouse secondary antibodies were used at 1:200 dilution. After incubation for 30 minutes and washing in PBS, the avidin-biotin complex was added and the slides were incubated at RT for 30 min. Then, the slides were washed in PBS and the peroxidase reaction was initiated using 0.06% diaminobenzidine (DAB) and 0.01% H 2 O 2 . After the last rinsing, the sections were counterstained with hematoxylin, and mounted under a cover slip. Negative controls, slides of ZA and PBS group were directly colored with anti-mouse secondary antibodies.
In order to evaluate α-smooth muscle actin immunoreactivity, the preparations were stained with α-smooth muscle actin antibody and examined under different magnifications. Then, positivestained cells were counted for immunscoring of α-smooth muscle actin expressed cells. If none of the cells were stained, the score was indicated as (-). Likewise, if the number of stained cells was between 1-10, 11-50, 51-100 and ≥100, the score was indicated as (+), (++), (+++) and (++++), respectively (23) .
Statistical analysis
The statistical analysis was performed using SPSS 12.0 (SPSS Inc, Chicago, IL, USA) for windows. Statistical analysis of data performed for drug treatments (two levels; placebo or ZA) as between rabbit factor; and anastomosis (two levels; present or not) as within rabbit factor with analysis of variance (ANOVA). If there were interactions between the factors in ANOVA, the Wilcoxon signed ranks test and the Mann-Whitney U test were used for paired and unpaired comparisons respectively . Chisquare test was used to evaluate the statistical difference of immunostaining between ZA-treated and placebo group. Data are shown as mean±SD (standard deviation); n indicates the number of animals. A p<0.05 was considered statistically significant.
Results

Morphometry
Morphometric examination of the anastomosed arteries from the PBS group showed different degrees of neointimal hyperplasia. The intimal cross-sectional area (112.509±61.179 μm2*1000 PBS anastomozed group vs. 22.618±4.263 μm2*1000 PBS control, p<0.01) and the ratio of intimal area to medial area (index) (0.347±0.292 PBS anastomozed group vs. 0.075±0.01 PBS control group, p<0.05) significantly increased in anastomosed arteries as compared to those in control arteries in placebo group (Fig. 1A, 1B, 1C, 1F, 2, 4) .
ZA treatment significantly decreased the neointimal hyperplasia (39.286±18.211 μm2*1000 ZA group vs. 112.509±61.179 μm2*1000 PBS group, p<0.01) and carotid artery intima/media index (0.112±0.072 ZA group vs. 0.347±0.292 PBS group, p<0.05) in anastomosed arteries (Fig. 1D, 1E, 2, 4) .
Medial cross-sectional area was not altered in anastomosed arteries in the placebo group (Fig. 3) . ZA treatment did not affect the medial cross-sectional area (Fig. 3) .
Luminal cross-sectional area was not affected by either intimal hyperplasia or ZA treatment (Fig. 5) .
Immunohistochemistry
Immunoscoring for α-smooth muscle actin antibody revealed that α-smooth muscle actin immunopositivity was significantly higher in the PBS group compared to ZA group (3.500±0.548 PBS group vs 2.333±0.516 ZA group, p<0.05) (Fig. 6, 7) .
Immunostaining with MMP-2 and MMP-9 antibodies showed that intensive positive immunostaining for MMP-2 and MMP-9 were observed in anastomosed carotid arteries compared to control arteries from placebo group (Fig. 8, 9 ). However, ZA treatment apparently decreased positive immunoreactivities of MMP-2 and MMP-9 in anastomosed carotid arteries (Fig. 8, 9 ).
Discussion
In the present study, we demonstrated that the injury by carotid artery anastomosis induces intensive neointimal hyperplasia, and increased intima/media index and α-smooth muscle actin immunopositivity in rabbits from placebo (PBS) group.
It was known that neointimal hyperplasia is the main stage in the pathogenesis of restenosis development after vascular injury (1) (2) (3) . It is also the main cause of late graft occlusions after vascular surgery (1-3) . Many of the studies showed that throughout the neointimal hyperplasia process, the MMP enzyme family plays an essential role in SMC proliferation and migration by degrading the ECM components, and contributes to neointimal hyperplasia process (5, 7, 24) . Development of intimal hyperplasia and early events of atherosclerosis are usually associated with the expression and activities of gelatinases (MMP-2 and MMP-9) (7, 9, 25). Similarly, in this study we investigated that the role of gelatinases in the development of neointimal hyperplasia in the rabbit model of carotid anastomosis. Consistent with the previous evidence, we observed that gelatinase expression which is evaluated by using immunohistochemistry apparently increased in anastomosed arteries of the rabbits from placebo group. The increased expressions of MMP-2 and MMP-9 in these arteries suggest tat MMP-2 and MMP-9 may have a regulatory role in SMC proliferation and migration even 28 days after vascular injury in the rabbit model of carotid anastomosis. Figure B) . In the slices with intensive neointimal hyperplasia, several recanalized areas were identified within the hyperplastic tissue occluding the lumen ( Figure 1A (→), 1B(* )). In anastomosed arteries from PBS group, it was observed that alignment of the circular SMCs within media layer was disrupted, and in some of these areas, SMCs were aligned heading toward the lumen ( Figure 1A, 1B) . Some infiltrated areas and an increase in the density of fibrous connective tissue were also observed ( Figure 1B (→) ). ZA treatment significantly decreased the neointimal hyper plasia in anastomosed arteries ( Figure 1D (→), 1E (→)). Disruption of the alignment of circular SMCs in the media layer was observed in ZA group, as were necrotic changes and mononuclear cellular infiltration around the sutured regions ( Figure 1D (* ) ). Mildly infiltrated areas were identified in the adventitia ( Figure 1D Indeed, it was shown that MMP-9 expression and activity increased at day 1 and decreased from day 7 after vascular injury in carotid arteries ligation model in mice and in carotid artery balloon injury model in pigs (9, 26) . Similarly, in carotid artery ligation model in mice, MMP-2 expression apparently increased at day 7 and proceeds to increase even 4weeks after vascular injury (9) . This evidences show that MMP-2 and MMP-9 have different expression patterns in at different time points (27) . But, in our study we demonstrated that MMP-2 and MMP-9 expressions appear to be similar at day 28 after vascular injury in rabbit model of carotid anastomosis. However, we have not determined the levels of gelatinases by zymography. This point requires further investigation. In this study, immunohistochemical stainings also demonstrated that MMP-2 was located in intima and adventitia, but MMP-9 was located in almost exclusively in adventitia. Unlikely, it was shown that MMP-9 immunoreactivity is massively expressed by intimal cells, but it is also expressed decreasingly by medial and adventitial cells in mouse carotid artery flow cessation model at day 28 (9) . Moreover, it was demonstrated that MMP-2 was located throughout the intima, whereas MMP-9 was localized almost exclusively to the region of endothelium at day 28 in bilateral common carotid interposition vein graft model in rabbits (28) . This discrepancy may result from the differences between experimental atherosclerosis models, although the immunoreactivities of gelatinases were investigated at the same time point in the related studies.
On the other hand, it was known that bisphosphonates reduce adhesion, invasion and proliferation and viability of tumor cells in tumor cell lines and some animal models (14, 15, 29) . Accordingly, zoledronic acid, the most potent one in biphosphonates family was shown to inhibit tumor burden and prevent tumor cell metastasis (30) . Furthermore, increasing studies have indicated that bisphosphonates could inhibit the development of experimental atherosclerosis (31, 32) and neointimal hyperplasia (33, 34) . Although in most of the studies, biphosphonates have been shown to have inhibitory effects on MMPs in tumor growth and invasion (16, 19) , their possible inhibitory effects on intimal hyperplasia and MMPs remains unclear.
Thus, in this study we investigated the effects of ZA on neointimal hyperplasia and gelatinase expression in the rabbit model of carotid artery. We also firstly showed that ZA, the most potent biphosponate using in the treatment of osteoporosis and bone resorption, inhibited neointimal hyperplasia and decreased α-smooth muscle actin immunopositivity and SMC intensity in anastomosed arteries of the rabbits from placebo group.
Our finding supports the view that bisphosphonates not only bind tightly to hydroxyapatite in the bone but they also concentrate in the arterial wall of both healthy and especially atheromatous rabbits (20) . Furthermore, the inhibitory effect of ZA on SMC score suggests that ZA might also have direct inhibitory effect on vascular SMCs. Indeed, Su et al. (35) reported that etidronate which is another bisphosphonate, inhibited the growth of vascular SMCs from spontaneous hypertensive rats. Similarly, Wu et al. (36) exerted that ZA concentration-dependently reduced proliferation, adhesion and migration of vascular SMCs in vitro.
We also reported for the first time that ZA inhibited increased gelatinase expression in anastomosed carotid arteries from placebo group. This result suggests that the inhibition of gelatinase enzyme contributes to the anti-atherosclerotic effects of ZA. Accordingly, Melani C at al. (18) showed that 0.1 mg/kg dose of ZA which we used in this study, inhibited increased MMP-9 expression and also decreased the levels of vascular endothelial growth factor (VEGF) in mammary tumor cells of mice. Besides, Giraudo et al. (37) reported that ZA significantly reduced MMP-9 Figure 8 . Representative photomicrographs of paraffin transverse sections of carotid arteries stained with MMP-2 antibody immunohistochemically. A1 and A2-placebo (PBS; phosphate buffer saline) control group; B1 and B2-placebo (PBS) group; C1 and C2-zoledronic acid (ZA) control group; D1 and D2-ZA group. (Original magnification x10, x40 and x100) Figure 9 . Representative photomicrographs of paraffin transverse sections of carotid arteries stained with MMP-9 antibody immunohistochemically. A1 ve A2-placebo (PBS; phosphate buffer saline) control group; B1 ve B2-PBS group; C1 ve C2-zoledronic acid (ZA) control group; D1 and D2-ZA group. (Original magnification x10, x40 and x100) expression by infiltrating macrophages and inhibited MMP-9 activity by reducing association of VEGF with its receptor on angiogenic endothelial cells in a mouse model of human cervical carcinogenesis. Additionally, ZA treatment was shown to decrease circulating levels of MMP-2, VEGF and basic fibroblast growth factor (bFGF) in metastatic breast cancer patients (38) . Furthermore, alendronate which is another bisphosphonate was exerted to reduce the secretion of MMP-2 and MMP-9 by metastatic PC-3 ML cells in mice (39) . Our findings related to the potential of MMP inhibitory effect of ZA on are consistent with all these evidence regarding its antitumor effects. The similarities between anti-atherosclerotic and antitumor effects of biphosphonates suggests that the similar underline mechanisms are responsible for these two proliferative process.
Study limitations
In this preliminary study, we evaluated expressions of gelatinase enzymes by immunohistochemistry, but we have not been able to determine pro and active gelatinase levels by zymography, due to the limited amount of arterial tissues from animals.
Conclusion
In conclusion, in the present study we demonstrated for the first time, that ZA which is the most potent member of the newest generation of bisphosphonates, inhibited neointimal hyperplasia and gelatinase upregulation in carotid artery anastomosis model in rabbits. This result suggests that the inhibition of gelatinase enzymes contributes to the antiatherosclerotic effects of ZA.
Combined data from the present study point out that ZA, which is the most potent inhibitor of osteoclast-mediated bone resorption in clinical practice, might be a promising agent to prevent neointimal hyperplasia and to increase vascular patency after vascular interventions due to its MMP inhibitory effect.
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